Relationship of Soluble Klotho and Early Stage of Diabetic Nephropathy: A Systematic Review and Meta-Analysis

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2022 Jun 13

PMID 35692408

Authors

Caihong Xin

Xin Sun

Zheng Li

Tianshu Gao

Affiliations

Soon will be listed here.

Abstract

Background: Diabetic nephropathy (DN) is a chronic microvascular complication caused by long-term hyperglycemia in patients with diabetes and an important cause of end-stage renal disease. Although some studies have shown that soluble Klotho(sKlotho) levels of patients with DN are lower than those without DN, in the early stage of patients with DN with normal renal function and albuminuria, the change in sKlotho is still controversial.

Aim: This meta-analysis was conducted to statistically evaluate sKlotho levels in patients with DN.

Methods: We searched the following electronic databases: Web of Science, Embase, PubMed, Google Scholar, and China National Knowledge Infrastructure (CNKI). The following search terms were used for the title or abstract: "diabetic kidney disease", "diabetic nephropathy", OR "DN" in combination with "Klotho". The meta-analysis results were presented as standardized mean differences (SMDs) with corresponding 95% confidence intervals (CIs).

Results: Fourteen articles were included in the meta-analysis. In our meta-analysis, we found that the sKlotho level in patients with DN was significantly lower than that in patients without DN (SMD: -1.52, 95% CI [-2.24, -0.80]), and it was also significantly lower in the early stage of DN (SMD: -1.65, 95% CI [-2.60, -0.70]).

Conclusions: This systematic review was the first to evaluate the relationship between sKlotho levels and DN. The sKlotho level was significantly lower in the early stages of DN, indicating that sKlotho might be a new biomarker of DN in the future.

Citing Articles

Association Between Serum α-Klotho Levels and Diabetic Kidney Disease Prevalence in Middle-Aged and Elderly US Patients with Diabetes: A Cross-Sectional Study Using NHANES 2007-2016 Data.

Ding S, Sun J, Wang L, Wu L, Liu W Diabetes Ther. 2025; 16(3):499-511.

PMID: 39928222 PMC: 11868003. DOI: 10.1007/s13300-024-01683-7.

The relationship of serum klotho levels and triglyceride glucose index-related indicators.

Zhou Y, Wang Y, Li F, Shi Y, Wu T, Li Y Lipids Health Dis. 2024; 23(1):399.

PMID: 39639327 PMC: 11619470. DOI: 10.1186/s12944-024-02379-4.

Klotho exerts protection in chronic kidney disease associated with regulating inflammatory response and lipid metabolism.

Liu J, Wang H, Liu Q, Long S, Wu Y, Wang N Cell Biosci. 2024; 14(1):46.

PMID: 38584258 PMC: 11000353. DOI: 10.1186/s13578-024-01226-4.

The Role of Autophagy in Type 2 Diabetic Kidney Disease Management.

Tseng C, Shah K, Chiu I, Hsiao L Cells. 2023; 12(23).

PMID: 38067119 PMC: 10705810. DOI: 10.3390/cells12232691.

Potential application of Klotho as a prognostic biomarker for patients with diabetic kidney disease: a meta-analysis of clinical studies.

Yu L, Sha M, Chen Y, Tan F, Liu X, Li S Ther Adv Chronic Dis. 2023; 14:20406223231213246.

PMID: 38058396 PMC: 10697044. DOI: 10.1177/20406223231213246.

References

Zhang L, Liu T . Clinical implication of alterations in serum Klotho levels in patients with type 2 diabetes mellitus and its associated complications. J Diabetes Complications. 2018; 32(10):922-930. DOI: 10.1016/j.jdiacomp.2018.06.002. View

Su X, Yang W . α-Klotho is an acute phase protein and altered by restraint stress in mice. Int J Clin Exp Pathol. 2014; 7(9):5922-6. PMC: 4203207. View

Xu Y, Sun Z . Molecular basis of Klotho: from gene to function in aging. Endocr Rev. 2015; 36(2):174-93. PMC: 4399270. DOI: 10.1210/er.2013-1079. View

Fountoulakis N, Maltese G, Gnudi L, Karalliedde J . Reduced Levels of Anti-Ageing Hormone Klotho Predict Renal Function Decline in Type 2 Diabetes. J Clin Endocrinol Metab. 2018; 103(5):2026-2032. DOI: 10.1210/jc.2018-00004. View

Guo J, Zheng H, Zhang W, Lou W, Xia C, Han X . Accelerated Kidney Aging in Diabetes Mellitus. Oxid Med Cell Longev. 2020; 2020:1234059. PMC: 7407029. DOI: 10.1155/2020/1234059. View

Huang J, Chuang C, Liu M, Lin S, Guh J, Chuang L . Klotho attenuates high glucose-induced fibronectin and cell hypertrophy via the ERK1/2-p38 kinase signaling pathway in renal interstitial fibroblasts. Mol Cell Endocrinol. 2014; 390(1-2):45-53. DOI: 10.1016/j.mce.2014.04.001. View

Samsu N . Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment. Biomed Res Int. 2021; 2021:1497449. PMC: 8285185. DOI: 10.1155/2021/1497449. View

Lin Y, Kuro-O M, Sun Z . Genetic deficiency of anti-aging gene klotho exacerbates early nephropathy in STZ-induced diabetes in male mice. Endocrinology. 2013; 154(10):3855-63. PMC: 3776873. DOI: 10.1210/en.2013-1053. View

Neyra J, Hu M . αKlotho and Chronic Kidney Disease. Vitam Horm. 2016; 101:257-310. PMC: 5658019. DOI: 10.1016/bs.vh.2016.02.007. View

10.

Shaw J, Sicree R, Zimmet P . Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2009; 87(1):4-14. DOI: 10.1016/j.diabres.2009.10.007. View

11.

Dogan B, Arikan I, Guler D, Keles N, Isbilen B, Isman F . Fibroblast growth factor-23 but not sKlotho levels are related to diastolic dysfunction in type 1 diabetic patients with early diabetic nephropathy. Int Urol Nephrol. 2016; 48(3):399-407. DOI: 10.1007/s11255-015-1190-y. View

12.

Drueke T, Massy Z . Circulating Klotho levels: clinical relevance and relationship with tissue Klotho expression. Kidney Int. 2012; 83(1):13-5. DOI: 10.1038/ki.2012.370. View

13.

Kuro-O M . Klotho in health and disease. Curr Opin Nephrol Hypertens. 2012; 21(4):362-8. DOI: 10.1097/MNH.0b013e32835422ad. View

14.

Kadoya H, Satoh M, Haruna Y, Sasaki T, Kashihara N . Klotho attenuates renal hypertrophy and glomerular injury in Ins2Akita diabetic mice. Clin Exp Nephrol. 2015; 20(5):671-678. DOI: 10.1007/s10157-015-1202-3. View

15.

Huang C . Regulation of ion channels by secreted Klotho: mechanisms and implications. Kidney Int. 2010; 77(10):855-60. DOI: 10.1038/ki.2010.73. View

16.

Nie F, Wu D, Du H, Yang X, Yang M, Pang X . Serum klotho protein levels and their correlations with the progression of type 2 diabetes mellitus. J Diabetes Complications. 2016; 31(3):594-598. DOI: 10.1016/j.jdiacomp.2016.11.008. View

17.

Kuro-O M . The Klotho proteins in health and disease. Nat Rev Nephrol. 2018; 15(1):27-44. DOI: 10.1038/s41581-018-0078-3. View

18.

Kim J, Hwang K, Park K, Kong I, Cha S . Biological Role of Anti-aging Protein Klotho. J Lifestyle Med. 2015; 5(1):1-6. PMC: 4608225. DOI: 10.15280/jlm.2015.5.1.1. View

19.

Paula Silva A, Mendes F, Carias E, Baptista Goncalves R, Fragoso A, Dias C . Plasmatic Klotho and FGF23 Levels as Biomarkers of CKD-Associated Cardiac Disease in Type 2 Diabetic Patients. Int J Mol Sci. 2019; 20(7). PMC: 6480092. DOI: 10.3390/ijms20071536. View

20.

Fineberg D, Jandeleit-Dahm K, Cooper M . Diabetic nephropathy: diagnosis and treatment. Nat Rev Endocrinol. 2013; 9(12):713-23. DOI: 10.1038/nrendo.2013.184. View